How can oncology infusion centers prepare for HRSA 2026 340B audits?

Oncology infusion centers should focus on complete drug administration documentation, ensuring each infusion ties to a qualified prescriber and a billable encounter. They must align billing and EHR data at the NDC and provider level, maintain monthly reconciliation of exceptions, and verify contract pharmacy claim matching to meet HRSA’s 2026 audit expectations.